RENALYTIX AI PLC ORD 0.25P (REG S) Market & Company News

18:23 Renalytix AI PLC Result of Placing & Total Voting Rights RNS
07:01 Renalytix AI PLC Proposed Placing to raise RNS
12.07.2019 07:53 RENALYTIX AI PLC ORD 0.25P (REG S) Renalytix welcomes Trump executive order on US kidney disease SMW
12.07.2019 07:00 Renalytix AI PLC US Exec Order on Advancing American Kidney Health RNS
09.07.2019 09:32 RENALYTIX AI PLC ORD 0.25P (REG S) Renalytix AI reports positive study results for kidney diagnostics technology SMW
09.07.2019 07:00 Renalytix AI PLC Positive Interim Results for Validation Study RNS
08.07.2019 07:00 Renalytix AI PLC FractalDx Positive Results Published in JASN RNS
01.07.2019 07:00 Renalytix AI PLC US CPT RNS
07.06.2019 07:00 Renalytix AI PLC Positive results from FractalDx study published RNS
04.06.2019 07:00 Renalytix AI PLC KidneyIntelX commercial scale production milestone RNS
28.05.2019 07:00 Renalytix AI PLC CLIA Certificate Number issued for Renalytix Lab RNS
21.05.2019 07:00 Renalytix AI PLC Expansion of FractalDx core investigator group RNS
07.05.2019 09:03 RENALYTIX AI PLC ORD 0.25P (REG S) Renalytix technology to be evaluated by University Medical Center Groningen SMW
07.05.2019 07:00 Renalytix AI PLC University Medical Center Groningen collaboration RNS
02.05.2019 14:05 Renalytix AI PLC Second Price Monitoring Extn RNS
02.05.2019 14:00 Renalytix AI PLC Price Monitoring Extension RNS
02.05.2019 07:00 Renalytix AI PLC FDA grants Breakthrough Device designation RNS
26.04.2019 18:20 EKF Diagnostics Hldg Acquisition of further interest in Renalytix AI RNS
26.04.2019 17:42 Renalytix AI PLC Director/PDMR Shareholding RNS
02.04.2019 12:55 Renalytix AI PLC Holding(s) in Company RNS
01.04.2019 09:11 RENALYTIX AI PLC ORD 0.25P (REG S) Renalytix publishes positive kidney disease study results SMW
01.04.2019 07:00 Renalytix AI PLC Publication of confirmation study results RNS
25.03.2019 07:00 Renalytix AI PLC Half-year Report RNS
22.03.2019 07:00 Renalytix AI PLC RenalytixAI Forms Core Investigator Group RNS
12.03.2019 07:00 Renalytix AI PLC Investor briefing RNS
14.02.2019 07:00 Renalytix AI PLC Appointment of Nomad and Joint Broker RNS
13.02.2019 07:00 Renalytix AI PLC Joint venture partnership agreement with AKESOgen RNS
06.02.2019 07:00 Renalytix AI PLC RenalytixAI Expands Leadership Team RNS
23.01.2019 09:41 RENALYTIX AI PLC ORD 0.25P (REG S) Renalytix AI kicks off clinical validation study for kidney disease product SMW
23.01.2019 07:00 Renalytix AI PLC Initiates Clinical Validation Study RNS
21.01.2019 07:00 Renalytix AI PLC Clarification re. lock-up restrictions RNS
02.01.2019 07:44 RENALYTIX AI PLC ORD 0.25P (REG S) Renalytix AI exercises option for an exclusive license for a portfolio of kidney transplant diagnostics SMW
02.01.2019 07:00 Renalytix AI PLC Exercise of Option for Exclusive License RNS
20.12.2018 17:20 Renalytix AI PLC Director/PDMR Shareholding RNS
20.12.2018 07:01 Renalytix AI PLC Planned appointment of joint broker & of NOMAD RNS
19.12.2018 18:28 Renalytix AI PLC Director Dealing RNS
17.12.2018 13:30 Renalytix AI PLC Holding(s) in Company RNS
09.11.2018 10:30 Renalytix AI PLC Holding(s) in Company RNS
08.11.2018 16:50 Renalytix AI PLC Holding(s) in Company RNS
08.11.2018 07:00 Renalytix AI PLC Director/PDMR Shareholding RNS
06.11.2018 07:00 Renalytix AI PLC RENX Admission to AIM and First Day of Dealings RNS
Showing 1 to 41 of 41